**Core Concept**
A radioresistant tumor is one that is less responsive to radiation therapy, meaning it does not shrink or respond significantly to radiation exposure. This resistance is often due to the tumor's inherent biological characteristics, such as its rapid growth rate, high metabolic activity, or specific molecular features. Understanding the radioresistance of tumors is crucial in oncology, as it influences treatment planning and the choice of therapeutic modalities.

**Why the Correct Answer is Right**
Tumors are considered radioresistant if they have a high capacity for DNA repair, rapid cell division, or specific molecular alterations that confer resistance to radiation-induced damage. For example, some tumors with high levels of homologous recombination repair (HRR) genes, such as BRCA1 and BRCA2, may be more resistant to radiation therapy. Additionally, tumors with high expression of certain proteins, like p53, can also exhibit radioresistance. In clinical practice, the radioresistance of tumors is often assessed using various biomarkers and imaging modalities to guide treatment decisions.

**Why Each Wrong Option is Incorrect**
**Option A:** This option is incorrect because it does not specify a characteristic that is commonly associated with radioresistance in tumors. While some tumors may exhibit rapid growth rates, this feature does not necessarily confer radioresistance.

**Option B:** This option is incorrect because it does not accurately describe a molecular mechanism that contributes to radioresistance. While certain molecular alterations can impact a tumor's response to radiation, this option does not provide a clear example.

**Option C:** This option is incorrect because it describes a characteristic that is actually associated with radiosensitivity, not radioresistance. Tumors with high levels of apoptosis or DNA damage may be more responsive to radiation therapy.

**Clinical Pearl / High-Yield Fact**
A key clinical correlation to remember is that tumors with high levels of homologous recombination repair (HRR) genes, such as BRCA1 and BRCA2, may exhibit radioresistance. This is because these genes play a critical role in repairing DNA damage induced by radiation, making these tumors more resistant to radiation therapy.

**Correct Answer:** C.